Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis C treated with direct-acting antiviral therapy in a resource limited setting: a prospective cohort study.

Ekubazgi KW, Dellil M, Woldegeorgis BZ, Berhane KA, Anagaw S, Fisseha H

Open source

DOI
10.1186/s12876-026-04776-8
Published
2026 Apr 1
Container
BMC gastroenterology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12876-026-04776-8,
  title = {Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis C treated with direct-acting antiviral therapy in a resource limited setting: a prospective cohort study.},
  author = {Ekubazgi KW and Dellil M and Woldegeorgis BZ and Berhane KA and Anagaw S and Fisseha H},
  year = {2026},
  journal = {BMC gastroenterology},
  doi = {10.1186/s12876-026-04776-8},
  url = {https://doi.org/10.1186/s12876-026-04776-8}
}

RIS

TY  - JOUR
TI  - Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis C treated with direct-acting antiviral therapy in a resource limited setting: a prospective cohort study.
AU  - Ekubazgi KW
AU  - Dellil M
AU  - Woldegeorgis BZ
AU  - Berhane KA
AU  - Anagaw S
AU  - Fisseha H
PY  - 2026
JO  - BMC gastroenterology
DO  - 10.1186/s12876-026-04776-8
UR  - https://doi.org/10.1186/s12876-026-04776-8
ER  - 

APA

KW, E., M, D., BZ, W., KA, B., S, A., & H, F. (2026). Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis C treated with direct-acting antiviral therapy in a resource limited setting: a prospective cohort study.. BMC gastroenterology. https://doi.org/10.1186/s12876-026-04776-8

Source records